Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
43.18
-19.47
-45.09%
Share Warrants & Outstandings
Total Reserve
0.95
44.62
-43.67
-97.87%
Shareholder's Funds
24.65
87.80
-63.15
-71.92%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-26.82
26.82
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
6.42
-6.42
-100.00%
Total Non-Current Liabilities
0.00
-20.40
20.40
100.00%
Current Liabilities
Trade Payables
0.00
0.48
-0.48
-100.00%
Other Current Liabilities
0.14
13.72
-13.58
-98.98%
Short Term Borrowings
0.44
70.22
-69.78
-99.37%
Short Term Provisions
0.00
7.02
-7.02
-100.00%
Total Current Liabilities
0.57
91.44
-90.87
-99.38%
Total Liabilities
25.23
158.84
-133.61
-84.12%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
157.12
-157.07
-99.97%
Less: Accumulated Depreciation
0.01
41.79
-41.78
-99.98%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
115.33
-115.29
-99.97%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.71
-0.69
-97.18%
Other Non Current Assets
0.00
9.73
-9.73
-100.00%
Total Non-Current Assets
0.07
125.78
-125.71
-99.94%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
1.43
-1.43
-100.00%
Sundry Debtors
0.60
13.88
-13.28
-95.68%
Cash and Bank
21.30
8.74
12.56
143.71%
Other Current Assets
0.00
1.74
-1.74
-100.00%
Short Term Loans and Advances
3.26
7.28
-4.02
-55.22%
Total Current Assets
25.16
33.06
-7.90
-23.90%
Net Current Assets (Including Current Investments)
24.59
-58.38
82.97
142.12%
Total Current Assets Excluding Current Investments
25.16
33.06
-7.90
-23.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
158.84
-133.61
-84.12%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
70.22
-69.78
-99.37%
Book Value per share (adjusted)
10.40
-5.43
15.83
291.53%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






